Healthcare | August 16, 2024
Fortis Hospital Mulund hosts India's first IFEM endorsed ECMO workshop for emergency medicine doctors
This two-day program was attended by 40 doctors & paramedical staff
This two-day program was attended by 40 doctors & paramedical staff
Getinge has a strong market share in India within several product segments
Women of all ages will get round-the-clock access to comprehensive treatment
Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month
Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India
The agreement will help ensure wider reach and access to patients in India
Subscribe To Our Newsletter & Stay Updated
